Vision Healthcare N.V.

Based in Belgium, Vision Healthcare N. V. operates a digital-first omni-channel platform that enhances consumer health and well-being through a diverse range of high-quality brands and products. Vision Healthcare N.

V. is a company focused on consumer health products. Founded in 2017 in Belgium, the company has undergone strategic growth, highlighted by its acquisition in May 2020 by Avista Capital Partners and VHC Investco for EUR 305 million, with both holding 50% shares. The company currently has its headquarters in Belgium with a commitment to expanding its operations.

The CEO, Geert Cools, along with Tim Schelling, has guided the company through this transformative period. Vision Healthcare operates as a comprehensive digital-first omni-channel platform, primarily focused on enhancing consumer health and well-being through a diverse range of high-quality brands and products. The company's core offerings include vitamins, nutritional supplements, and wellness products, which are designed to support various aspects of health and lifestyle. Brands such as BeSoHappy®, Tummy Tox®, and VitaminExpress provide consumers with tailored solutions for preventive health, body confidence, and nutritional needs.

The platform’s direct-to-consumer approach allows users to access these products conveniently online, thereby fostering strong consumer relationships. Vision Healthcare serves a wide customer base across Europe, with products available in several key markets, including the Nordic countries, the DACH region (Germany, Austria, Switzerland), the Benelux, and Southern Europe. Vision Healthcare generates revenue through a direct-to-consumer model, emphasizing subscriptions and online sales. For the most recent year, 2024, the company reported a revenue of EUR 12,972,818.

70, alongside an EBITDA of EUR -1,222,844. 20. Customers purchase products directly from the company's various brand websites, including flagship offerings such as Flinndal and Lectinect®. The company also engages in partnerships that enhance its market reach, with pricing strategies structured to maintain accessibility while delivering quality, aligning products with the needs of health-conscious consumers across its operating regions.

Following its acquisition completed on May 29, 2020, Vision Healthcare N. V. intends to leverage its newly secured funding of EUR 305 million to support the growth of new product lines and the expansion into new geographical markets. The company plans to introduce additional health and wellness products aimed at enhancing consumer health by 2025.

Additionally, it is targeting further expansion into new markets beyond its current European presence, with a focus on increasing its footprint in emerging markets within Asia and the Americas. The investment from Avista Capital Partners will facilitate these growth initiatives, focusing on enhancing its direct-to-consumer capabilities.